Patient preference: messages for the wider adoption of renal denervation in the real world

Affiliations

¹ Cardiovascular Center and Divisions of Cardiology and Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei City, Taiwan. tdwang@ntu.edu.tw.

Editorial

Tzung-Dau Wang. Hypertens Res. 2022 Feb.

. 2022 Feb;45(2):244-245.

doi: 10.1038/s41440-021-00828-6. Epub 2021 Dec 24.

¹ Cardiovascular Center and Divisions of Cardiology and Hospital Medicine, Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei City, Taiwan. tdwang@ntu.edu.tw.

No abstract available

Comment on

Effects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials.
Ogoyama Y, Tada K, Abe M, Nanto S, Shibata H, Mukoyama M, Kai H, Arima H, Kario K. Ogoyama Y, et al. Hypertens Res. 2022 Feb;45(2):210-220. doi: 10.1038/s41440-021-00761-8. Epub 2021 Oct 17. Hypertens Res. 2022. PMID: 34657140

1. Collaboration NCDRF. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: A pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398:957–80. - DOI
1. Lin HJ, Wang TD, Yu-Chih Chen M, Hsu CY, Wang KL, Huang CC, et al. 2020 consensus statement of the taiwan hypertension society and the taiwan society of cardiology on home blood pressure monitoring for the management of arterial hypertension. Acta Cardiol Sin. 2020;36:537–61. - PubMed - PMC
1. Pan HY, Lin HJ, Chen WJ, Wang TD. Prevalence, treatment, control and monitoring of hypertension: a nationwide community-based survey in taiwan, 2017. Acta Cardiol Sin. 2020;36:375–81. - PubMed - PMC
1. Wang TD, Chen YH, Huang CH, Chen WJ, Chen MF. Bidirectional adherence changes and associated factors in patients switched from free combinations to equivalent single-pill combinations of antihypertensive drugs. Hypertension. 2014;63:958–67. - DOI
1. Lin JL, Huang PH, Yeh HI, Li YH. Appropriate use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for atherosclerotic cardiovascular disease: Comparison of recommendations from different guidelines or consensus around the world. Acta Cardiol Sin. 2020;36:403–08. - PubMed - PMC